Royal DSM N.V., the global Life Sciences and Materials Sciences Company headquartered in the Netherlands, announces that it holds a 4.95% stake in Danisco which has been acquired some years ago.
DSM currently owns 2.36 million shares of Danisco, which are traded at the Copenhagen Stock Exchange. It has been building its shareholding in 2007 and beginning 2008.
DSM has taken notice of the recommended bid that has been announced by DuPont at a price of DKK 665 per share. If DSM sells its shares for DKK 665, it will have a non-recurring book profit of approximately EUR 129 million before tax.
DSM is not considering a competitive bid.
DSM - the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic performance, environmental quality and social responsibility, which it pursues simultaneously and in parallel. DSM has annual net sales of about EUR8 billion and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com